CorMedix (CRMD) Gross Profit (QoQ) (2014 - 2025)
CorMedix (CRMD) Gross Profit (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | CorMedix | 4.93 Mn | -150.27 Mn | 107.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.28% |
| Sep 30, 2025 | 145.76% |
| Jun 30, 2025 | 1.04% |
| Mar 31, 2025 | 24.81% |
| Dec 31, 2024 | 178.89% |
| Sep 30, 2024 | 3,534.91% |
| Jun 30, 2024 | 136.20% |
| Dec 31, 2022 | 447.79% |
| Sep 30, 2022 | -74.44% |
| Jun 30, 2022 | 242.46% |
| Mar 31, 2022 | -27.19% |
| Dec 31, 2021 | -35.07% |
| Sep 30, 2021 | 307.25% |
| Jun 30, 2021 | -123.16% |
| Mar 31, 2021 | 1,873.52% |
| Dec 31, 2020 | -111.58% |
| Sep 30, 2020 | 578.18% |
| Jun 30, 2020 | -110.73% |
| Mar 31, 2020 | 219.63% |
| Dec 31, 2019 | -9.49% |